Current Value
$17.271 Year Return
Current Value
$17.271 Year Return
Yahoo
If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...
Yahoo
Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin antibiotic, in the United States. In April, the FDA approved Zevtera for three specific treatment indications, and it is the only FDA-approved methicillin-resistant Staphylococcus aureus, or MRSA, cephalosporin antibiotic for treating adult patients with Staphylococcus aureus bloodstream infections and
Finnhub
Allschwil, Switzerland - Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections,...
Finnhub
BURLINGAME - Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. , today announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica...
Yahoo
BURLINGAME, Calif., December 16, 2024--Innoviva Specialty Therapeutics, Inc., ("IST") a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), for the commercialization of Zevtera® (ceftobiprole), an advanced-generation cephalosporin antibiotic, in the United States.
Yahoo
BURLINGAME, Calif., November 26, 2024--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Citi 2024 Global Healthcare Conference in Miami, FL on Thursday,
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EW | -12.78% | $43.30B | -0.82% | 0.00% |
PULM | -12.36% | $21.95M | +206.95% | 0.00% |
HUSA | -11.33% | $21.99M | -1.18% | 0.00% |
STG | -9.48% | $28.83M | -36.52% | 0.00% |
FIVE | -9.12% | $5.68B | -45.85% | 0.00% |
CBOE | -8.32% | $19.99B | +5.68% | 1.23% |
FATBB | -7.95% | $88.50M | -7.04% | 10.87% |
CEG | -7.09% | $95.45B | +170.29% | 0.48% |
BEST | -6.96% | $31.63M | +5.85% | 0.00% |
VIRT | -6.55% | $2.98B | +81.55% | 2.80% |
CORZ | -5.86% | $3.92B | +917.47% | 0.00% |
CYCN | -3.86% | $8.92M | -9.86% | 0.00% |
DELL | -3.82% | $80.39B | +44.71% | 1.55% |
DLTR | -3.73% | $15.68B | -46.30% | 0.00% |
HIHO | -3.72% | $8.54M | -3.48% | 6.22% |
CANG | -3.64% | $338.97M | +377.55% | 0.00% |
ROOT | -3.59% | $1.17B | +689.06% | 0.00% |
VST | -3.40% | $56.73B | +325.11% | 0.54% |
SUZ | -3.38% | $12.08B | -8.62% | 3.34% |
MAGN | -3.24% | $650.28M | +4.84% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LXP | 48.52% | $2.27B | -19.08% | 6.83% |
DOX | 46.11% | $9.27B | -10.02% | 2.34% |
SJW | 45.38% | $1.51B | -28.75% | 3.47% |
AWR | 45.35% | $2.68B | -9.88% | 2.53% |
ALEX | 45.27% | $1.24B | -6.12% | 5.25% |
UVSP | 45.24% | $803.33M | +36.53% | 3.01% |
PEB | 44.89% | $1.57B | -15.14% | 0.31% |
CDP | 44.61% | $3.30B | +14.22% | 4.05% |
STAG | 43.90% | $5.90B | -16.02% | 4.56% |
DEA | 43.82% | $1.18B | -17.05% | 9.47% |
EPR | 43.72% | $3.35B | -6.76% | 7.67% |
APLE | 43.40% | $3.50B | -11.13% | 6.61% |
VRE | 43.16% | $1.43B | -0.96% | 1.72% |
SRCE | 42.96% | $1.35B | +6.17% | 2.56% |
YORW | 42.80% | $438.70M | -17.25% | 2.80% |
ACIW | 42.62% | $5.39B | +70.06% | 0.00% |
ESS | 42.41% | $17.47B | +9.16% | 3.56% |
GNL | 42.37% | $1.64B | -23.52% | 17.29% |
ACRE | 42.23% | $296.71M | -47.03% | 18.53% |
BXP | 42.23% | $10.78B | -2.59% | 5.75% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VNET | -0.05% | $1.44B | +128.22% | 0.00% |
TGS | 0.06% | $2.22B | +121.72% | 0.00% |
PRPO | 0.06% | $9.09M | +14.66% | 0.00% |
NXTC | 0.10% | $22.38M | -31.12% | 0.00% |
EDU | 0.12% | $10.07B | -19.94% | 0.00% |
AMED | -0.15% | $3.01B | -2.52% | 0.00% |
ASPS | -0.15% | $21.00M | -71.84% | 0.00% |
EDN | -0.17% | $816.98M | +100.27% | 0.00% |
EQNR | 0.20% | $69.10B | -11.80% | 5.26% |
NEXA | -0.21% | $848.93M | -8.17% | 0.00% |
QXO | -0.22% | $6.41B | -84.42% | 0.00% |
FSLR | 0.22% | $20.26B | +17.95% | 0.00% |
MSDL | 0.23% | $1.82B | +0.42% | 9.78% |
DLNG | 0.24% | $198.00M | +82.99% | 0.89% |
CEPU | 0.24% | $2.29B | +72.69% | 0.00% |
ARLP | -0.30% | $3.48B | +22.64% | 10.31% |
CMRE | 0.35% | $1.50B | +16.29% | 3.72% |
UUU | -0.36% | $5.37M | +44.10% | 0.00% |
NNE | 0.38% | $846.86M | +541.50% | 0.00% |
POWL | 0.40% | $2.79B | +184.89% | 0.48% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XSLV | 54.50% | $293.93M | 0.25% |
SMMV | 53.72% | $303.68M | 0.2% |
XMLV | 51.99% | $787.12M | 0.25% |
XSHD | 51.33% | $62.78M | 0.3% |
FVD | 51.27% | $9.18B | 0.6% |
RIET | 50.84% | $71.16M | 0.5% |
SMDV | 49.68% | $694.09M | 0.4% |
PBE | 49.51% | $254.47M | 0.58% |
SLYV | 49.36% | $3.96B | 0.15% |
IJS | 49.32% | $7.50B | 0.18% |
RSPA | 49.29% | $270.45M | 0% |
KBWY | 49.27% | $220.33M | 0.35% |
XPH | 49.19% | $158.66M | 0.35% |
PRFZ | 49.03% | $2.55B | 0.39% |
FSMD | 49.01% | $669.24M | 0.16% |
USMV | 49.00% | $22.47B | 0.15% |
VIOV | 48.89% | $1.40B | 0.15% |
PEY | 48.78% | $1.18B | 0.53% |
IJR | 48.64% | $87.67B | 0.06% |
SPSM | 48.62% | $12.41B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GCC | -0.25% | $130.49M | 0.55% |
BCI | -0.33% | $1.31B | 0.26% |
MEAR | 0.37% | $772.54M | 0.25% |
CMDY | 0.41% | $287.70M | 0.28% |
GBIL | 0.61% | $5.82B | 0.12% |
BCD | -0.88% | $233.64M | 0.3% |
TBLL | -1.53% | $2.00B | 0.08% |
DBC | -1.75% | $1.30B | 0.87% |
CCOR | 1.86% | $83.85M | 1.18% |
WEAT | 1.92% | $119.67M | 0.28% |
AGZD | -2.12% | $142.77M | 0.23% |
XBIL | -2.17% | $641.82M | 0.15% |
MSOS | 2.37% | $474.12M | 0.83% |
CANE | 2.43% | $12.08M | 0.29% |
KRBN | -2.51% | $194.27M | 0.85% |
PWZ | 2.56% | $705.44M | 0.28% |
PDBC | -2.61% | $4.15B | 0.59% |
CNBS | 3.43% | $12.78M | 0.77% |
FTGC | -3.70% | $2.25B | 1.02% |
IBMN | 3.88% | $488.18M | 0.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -30.00% | $195.31M | 0.85% |
TAIL | -19.16% | $65.56M | 0.59% |
DBA | -13.69% | $790.77M | 0.93% |
UNG | -10.80% | $790.37M | 1.06% |
CTA | -9.34% | $497.20M | 0.76% |
USCI | -8.69% | $193.45M | 1.07% |
DBE | -7.97% | $48.12M | 0.77% |
UUP | -7.75% | $607.07M | 0.77% |
USDU | -7.08% | $381.18M | 0.5% |
EQLS | -6.86% | $9.16M | 1% |
COMT | -5.59% | $688.84M | 0.48% |
DBO | -5.40% | $214.31M | 0.77% |
GSG | -4.43% | $1.02B | 0.75% |
FTGC | -3.70% | $2.25B | 1.02% |
PDBC | -2.61% | $4.15B | 0.59% |
KRBN | -2.51% | $194.27M | 0.85% |
XBIL | -2.17% | $641.82M | 0.15% |
AGZD | -2.12% | $142.77M | 0.23% |
DBC | -1.75% | $1.30B | 0.87% |
TBLL | -1.53% | $2.00B | 0.08% |